antifungal agent

(redirected from clotrimazole)
Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for antifungal agent

References in periodicals archive ?
In our immunocompromised group, 4 patients did not respond to treatment with clotrimazole ear drops, but theywere successfully treated with fluconazole ear drops.
Clotrimazole was registered in Germany for the first time in 1973 and launched in the market under the brand name Canesten.
The mycologic cure rate at 2 weeks was 62% with butenafine and 18% with clotrimazole.
Maintenance regimens that have demonstrated effectiveness in published studies include 150 mg of oral fluconazole once per week, oral ketoconazole at 100 mg once daily oral itraconazole at 100 mg once daily a single 500-mg tablet of clotrimazole administered intravaginally once weekly or a daily azole cream.
David Klaum, Vice President of Sales and Marketing, stated, "With Clotrimazole & Betamethasone Dipropionate Lotion joining Fougera's Clotrimazole & Betamethasone Dipropionate Cream, we have expanded this important product line, thereby increasing the prescription choices for both health care professionals and their patients.
miconazole, clotrimazole, tolnaftate, and nystatin) is ototoxic.
Taro manufactures an extensive line of store-brand vaginal antifungal creams, including clotrimazole and miconazole nitrate products in various strengths.
Tenders are invited for Cream Clotrimazole With Beclomethasone/Betamethason, 15Gm/20Gm
Amphotericin is adequate, but clotrimazole is better for eradicating the Aspergillus that we see in ear canals.
Healthcare Network Solutions (BULLETIN BOARD: HNWS) / Nova Biogenetics discovers free radical attachment with Clotrimazole and Nova's antimicrobial.
Food and Drug Administration ("FDA") for its Abbreviated New Drug Application ("ANDA") for clotrimazole and betamethasone dipropionate lotion ("C/B lotion").
This study, utilizing a clotrimazole lacquer formulation containing Bentley's proprietary drug delivery technology (CPE-215(R)), revealed that, of 18 patients who completed 48 weeks of therapy, 17 (94%) showed varying degrees of improvement over their baseline condition.